Skip to main content
Chemomab Therapeutics Ltd. logo

Chemomab Therapeutics Ltd. — Investor Relations & Filings

Ticker · CMMB ISIN · US16385C1045 US Manufacturing
Filings indexed 332 across all filing types
Latest filing 2020-04-06 Proxy Solicitation & In…
Country US United States of America
Listing US CMMB

About Chemomab Therapeutics Ltd.

https://www.chemomab.com/

Chemomab Therapeutics Ltd. is a clinical-stage biotechnology company developing therapeutics for fibro-inflammatory diseases with high unmet medical needs. The company's scientific platform is based on the discovery of the soluble protein CCL24's central role in driving the cycle of fibrosis and inflammation. Its lead product candidate, nebokitug (CM-101), is a first-in-class monoclonal antibody designed to neutralize CCL24, thereby interfering with the primary pathways that promote these conditions. Nebokitug has demonstrated disease-modifying potential in multiple clinical trials and has received Orphan Drug and Fast Track designations from the U.S. FDA for the treatment of primary sclerosing cholangitis (PSC). Following positive Phase 2 results, the company is preparing for a potential Phase 3 trial for nebokitug in PSC.

Recent filings

Filing Released Lang Actions
DEF 14A
Proxy Solicitation & Information Statement
2020-04-06 English
Proxy Solicitation & Information Statement 2020
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a letter from the company to the SEC responding to comments on a preliminary proxy statement filed on Schedule 14A. It discusses revisions to the proxy statement and mentions proposals related to amendments to the Articles of Association and compensation policy. The document does not contain the proxy statement itself but is related to it. The content is focused on shareholder meeting materials and voting proposals, which aligns with proxy solicitation and information statements. The document length is short (2667 characters), and it is a correspondence related to the proxy statement, not the full proxy statement itself. However, since it is a detailed response about the proxy statement and includes substantive information about proposals, it is best classified as Proxy Solicitation & Information Statement (PSI).
2020-04-06 English
SC 13D/A
Major Shareholding Notification
2020-03-31 English
FORM 14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Proxy Statement filed as a Schedule 14A with the SEC, which is used to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It includes details about the meeting date, location, agenda items such as election of directors, approval of compensation policy, amendments to articles of association, and reappointment of auditors. The document is not the actual AGM report or voting results but the solicitation material for the AGM. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length is substantial and contains detailed information for shareholders to make informed voting decisions, consistent with a proxy statement.
2020-03-30 English
FORM S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as equity-based incentive plans. It includes details about the registration of additional shares under the 2017 Equity-Based Incentive Plan, references to previous filings, and signatures of company officers. It is not a financial report, earnings release, or management discussion, but a regulatory filing related to securities registration. Therefore, it fits best under the category of Regulatory Filings (RNS). The document length and content confirm it is not a brief announcement or a report publication announcement but a full registration statement filing.
2020-03-17 English
FORM 10-K
Annual Report FY 2019
2020-03-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.